Immuron Limited (IMC.AX)
Makes antibody-based medicines to prevent travelers' diarrhea and treat digestive infections.
0.03-0.08%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-46.0%
The outlook
IMC.AX is trading near its 52-week lows, well below both its 50- and 200-day moving averages, signaling a weak near-term trend. The stock sits in the lower portion of its annual range, and analyst coverage appears minimal based on the data provided. Current positioning reflects a bearish lean among available metrics.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range11% of the way from its 52-week low to high
Market cap
$11.0M
52-wk high
0.10
52-wk low
0.03
50-day avg
0.04
200-day avg
0.04
Trailing P/E
—